Annual Long Term Debt
$151.00 K
+$151.00 K+100.00%
December 31, 2023
Summary
- As of February 7, 2025, RSLS annual long term debt is $151.00 thousand, with the most recent change of +$151.00 thousand (+100.00%) on December 31, 2023.
- During the last 3 years, RSLS annual long term debt has fallen by -$9.18 million (-98.38%).
- RSLS annual long term debt is now -98.63% below its all-time high of $11.00 million, reached on December 31, 2008.
Performance
RSLS Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$77.00 K
-$26.00 K-25.24%
September 30, 2024
Summary
- As of February 7, 2025, RSLS quarterly long term debt is $77.00 thousand, with the most recent change of -$26.00 thousand (-25.24%) on September 30, 2024.
- Over the past year, RSLS quarterly long term debt has dropped by -$98.00 thousand (-56.00%).
- RSLS quarterly long term debt is now -99.31% below its all-time high of $11.17 million, reached on June 30, 2009.
Performance
RSLS Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
RSLS Long Term Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +100.0% | -56.0% |
3 y3 years | -98.4% | +100.0% |
5 y5 years | +100.0% | -68.3% |
RSLS Long Term Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | -100.0% | -61.1% | -100.0% |
5 y | 5-year | -98.4% | -100.0% | -99.2% | -100.0% |
alltime | all time | -98.6% | -100.0% | -99.3% | -100.0% |
ReShape Lifesciences Long Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $77.00 K(-25.2%) |
Jun 2024 | - | $103.00 K(-18.9%) |
Mar 2024 | - | $127.00 K(-15.9%) |
Dec 2023 | $151.00 K(>+9900.0%) | $151.00 K(-13.7%) |
Sep 2023 | - | $175.00 K(-11.6%) |
Jun 2023 | - | $198.00 K(>+9900.0%) |
Dec 2022 | $0.00(-100.0%) | $0.00(0.0%) |
Jun 2022 | - | $0.00(-100.0%) |
Mar 2022 | - | $86.00 K(>+9900.0%) |
Sep 2021 | - | $0.00(0.0%) |
Jun 2021 | - | $0.00(-100.0%) |
Mar 2021 | - | $82.00 K(-99.1%) |
Dec 2020 | $9.33 M(+1856.2%) | $9.33 M(+3739.9%) |
Sep 2020 | - | $243.00 K(-24.8%) |
Jun 2020 | - | $323.00 K(-19.7%) |
Mar 2020 | - | $402.00 K(-15.7%) |
Dec 2019 | $477.00 K(>+9900.0%) | $477.00 K(-13.6%) |
Sep 2019 | - | $552.00 K(-11.8%) |
Jun 2019 | - | $626.00 K(-10.6%) |
Mar 2019 | - | $700.00 K(>+9900.0%) |
Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
Sep 2016 | - | $1.24 M(-84.2%) |
Jun 2016 | - | $7.83 M(+53.1%) |
Mar 2016 | - | $5.12 M(+830.6%) |
Dec 2015 | $549.80 K(-80.8%) | $549.80 K(-41.0%) |
Jun 2014 | - | $932.10 K(-51.0%) |
Mar 2014 | - | $1.90 M(-33.7%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2013 | $2.87 M(-57.1%) | $2.87 M(-25.1%) |
Sep 2013 | - | $3.83 M(-20.0%) |
Jun 2013 | - | $4.78 M(-16.6%) |
Mar 2013 | - | $5.73 M(-14.2%) |
Dec 2012 | $6.68 M(+132.0%) | $6.68 M(-12.4%) |
Sep 2012 | - | $7.63 M(-11.1%) |
Jun 2012 | - | $8.58 M(+91.7%) |
Mar 2012 | - | $4.48 M(+55.4%) |
Dec 2011 | $2.88 M(-42.2%) | $2.88 M(-15.9%) |
Sep 2011 | - | $3.42 M(-13.4%) |
Jun 2011 | - | $3.96 M(-11.7%) |
Mar 2011 | - | $4.48 M(-10.1%) |
Dec 2010 | $4.98 M(+28.4%) | $4.98 M(+21.1%) |
Sep 2010 | - | $4.11 M(-16.4%) |
Jun 2010 | - | $4.92 M(+68.5%) |
Mar 2010 | - | $2.92 M(-24.7%) |
Dec 2009 | $3.88 M(-64.7%) | $3.88 M(-58.9%) |
Sep 2009 | - | $9.45 M(-15.4%) |
Jun 2009 | - | $11.17 M(+14.5%) |
Mar 2009 | - | $9.75 M(-11.3%) |
Dec 2008 | $11.00 M(+82.7%) | $11.00 M(+228.7%) |
Sep 2008 | - | $3.35 M(-21.5%) |
Jun 2008 | - | $4.26 M(-17.3%) |
Mar 2008 | - | $5.15 M(-14.4%) |
Dec 2007 | $6.02 M(+248.4%) | $6.02 M(+17.3%) |
Sep 2007 | - | $5.13 M(+197.0%) |
Dec 2006 | $1.73 M(-76.5%) | $1.73 M(-76.5%) |
Dec 2005 | $7.34 M | $7.34 M |
FAQ
- What is ReShape Lifesciences annual long term debt?
- What is the all time high annual long term debt for ReShape Lifesciences?
- What is ReShape Lifesciences annual long term debt year-on-year change?
- What is ReShape Lifesciences quarterly long term debt?
- What is the all time high quarterly long term debt for ReShape Lifesciences?
- What is ReShape Lifesciences quarterly long term debt year-on-year change?
What is ReShape Lifesciences annual long term debt?
The current annual long term debt of RSLS is $151.00 K
What is the all time high annual long term debt for ReShape Lifesciences?
ReShape Lifesciences all-time high annual long term debt is $11.00 M
What is ReShape Lifesciences annual long term debt year-on-year change?
Over the past year, RSLS annual long term debt has changed by +$151.00 K (+100.00%)
What is ReShape Lifesciences quarterly long term debt?
The current quarterly long term debt of RSLS is $77.00 K
What is the all time high quarterly long term debt for ReShape Lifesciences?
ReShape Lifesciences all-time high quarterly long term debt is $11.17 M
What is ReShape Lifesciences quarterly long term debt year-on-year change?
Over the past year, RSLS quarterly long term debt has changed by -$98.00 K (-56.00%)